Sign in
Taking people in United StatesNo phase

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Key facts

Who runs it
Children's Hospital of Philadelphia
Where
Atlanta, Baltimore, Philadelphia, and St Louis, United StatesSee the 4 sites
Trial code
Status
Recruiting
People taking part
52,500 people, planned
Started
21 Aug 2023
Planned end
May 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Multifaceted de-implementation strategy to reduce vancomycin overuse
Record updated
19 September 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Other criteria

  • Patient Inclusion Criteria:
  • Admitted to one of the participating PICUs during the study period; Patient Exclusion Criteria:
  • None; Clinician Inclusion Criteria:
  • PICU prescribing clinician (including attending physicians, fellows, residents, nurse practitioners, and physician assistants) OR sepsis stakeholder (leader of sepsis quality improvement work, medical director) at one of the participating sites at the time the survey is deployed
  • Age ≥ 18 years old
  • Employed by one of the participating sites; Clinician Exclusion Criteria:
  • Volunteers or other non-employee hospital staff
  • Limited English proficiency

This trial is currently available in United States.

  • Children's Healthcare of AtlantaAtlanta, United StatesContact: Preeti Jaggi, MDTaking people
  • Johns Hopkins Children's CenterBaltimore, United StatesContact: Pranita Tamma, MD, MPHTaking people
  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Kathleen Chiotos, MD, MSCETaking people
  • St. Louis Children's HospitalSt Louis, United StatesContact: Evan Facer, DOTaking people

About the trial

What the trial wants to find out

The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU).

Read full original descriptionShow less

There are two groups of subjects in this study: PICU clinicians/sepsis stakeholders and patients admitted to one of the participating PICUs during the study period. The intervention will at a minimum include:

* Implementation of a clinical guideline indicating when vancomycin should and should not be used * Unit-level feedback on overall vancomycin use within and across centers * Clinician education.

The 2 groups in the trial

  • PICU Clinicians and Sepsis stakeholdersOther group

    Clinicians and sepsis stakeholders in the participating sites will be primarily recruited via email. During the course of this multifaceted intervention: * All the PICU (Pediatric Intensive Care Unit) prescribing clinicians and sepsis stakeholders in the participating sites will receive clinical guidelines, unit-level feedback reports, and education on Vancomycin use during the intervention. * Investigators will perform semi-structured interviews with 90 PICU clinicians and sepsis stakeholders. * Surveys will be sent to all eligible clinicians, estimated to be up to 2500 individuals across the 4 sites. These structured surveys will be done at baseline and at 9 months post-implementation.

    Treatment: Multifaceted de-implementation strategy to reduce vancomycin overuse

  • PICU Patients with suspected sepsisNo study treatment, for comparison

    Research procedures involving patients will be limited to medical record review. This medical record review will help inform the intervention directed at PICU clinicians/stakeholders and the assessment of study outcomes. Approximately 50,000 patients will participate in the study. Data elements will be collected at each site and stored as password-protected Comma-separated values (CSV) files. These files will not contain any direct Protected Health Information (PHI) but will contain elements of date (e.g., date of admission, date of suspected sepsis episode). The study Identification (ID) number will be used to identify each unique patient. Each site will collect and store data in compliance with the Children's Hospital of Philadelphia (CHOP) and local Institutional Review Board (IRB) policies.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis (REVAMP-Sepsis)
Record updated
19 September 2025